Mycophenolate mofetil superior to azathioprine: Slows vascular disease progression after transplant

Researchers reported today that patients treated with CellCept (mycophenolate mofetil), a drug used to prevent rejection in organ transplantation, have significantly lower progression of intimal thickening, or thickening of the inner artery walls, compared with azathioprine (AZA). Intimal thickening is becoming increasingly important as a surrogate marker for long-term outcomes after heart transplantation. The study used intravascular ultrasound (IVUS) to measure intimal thickening in heart transplant patients immediately after surgery and one year later.

"These findings support published registry data that show significantly increased survival rates in CellCept-treated patients at three years," said Jon A. Kobashigawa, M.D., professor of medicine at the University of California, Los Angeles, Medical Center, and lead investigator of the study.

"Intimal thickening, as measured by IVUS, is a key indicator of vascular disease progression. These important data therefore confirm that heart transplant patients treated with CellCept have significantly less progression of intimal thickening than those treated with AZA. The prospect of achieving better long-term outcomes by slowing the progression of vascular disease is a significant benefit for transplant patients and the surgeons who treat them."

In the CellCept-treated group, only 23% of patients had an increase in intimal thickness of > 0.3mm versus 43% of patients treated with AZA. Studies have shown that patients with changes in intimal thickening of more than 0.3mm are more likely to have poor outcomes, such as myocardial infarction, organ failure and death.

Presented at the International Society for Heart and Lung Transplantation scientific sessions, the study used a more modern and clinically relevant site-to-site IVUS analysis of heart transplant patients to reanalyze intimal thickness in patients in the pivotal CellCept trial published in 1998.

The an

Contact: Lauren Mason
International Society for Heart and Lung Transplantation

Page: 1 2

Related medicine news :

1. Tacrolimus + mycophenolate mofetil & steroids: Safe, effective in preventing acute cardiac rejection
2. Kinder, gentler procedure gives superior results for stem cell transplants
3. Therapy, medication combination superior for children with obsessive-compulsive disorder
4. Universit de Montral study shows superior sound-location skills in the blind
5. CellCept(R) registry data demonstrated superior long-term organ transplant outcomes
6. Wavefront LASIK demonstrated superior to conventional LASIK
7. Transvaginal ultrasound superior to transrectal ultrasound for staging rectal cancer in women
8. MRI superior to ultrasound in predicting cerebral palsy in preterm infants
9. Linezolid is superior treatment for drug-resistant pneumonia
10. PET scans superior in revealing response to treatment for gastrointestinal stromal tumors
11. Endovascular coil superior to neurosurgery for treatment of brain haemorrhage

Post Your Comments:

(Date:3/20/2019)... SAN JOSE, Calif. (PRWEB) , ... March 20, ... ... safety net health plan for Santa Clara County, announced that the National Committee ... Cal MediConnect (Medicare-Medicaid Plan) line of business. NCQA is a private, not-for-profit organization ...
(Date:3/20/2019)... ... 20, 2019 , ... TSI Healthcare, a national ... Electronic Health Record (EHR) solutions, received multiple top awards in the 2019 ... consecutive year TSI Healthcare has been honored by this selective international organization. In ...
(Date:3/20/2019)... ... 20, 2019 , ... EBSCO Health , the leading ... announced the certification of two decision aids by the Washington State Health Care ... Test: Yes or No? Currently, Washington is the only state requiring certification for ...
(Date:3/20/2019)... ... 2019 , ... The American Board of Family Medicine (ABFM) ... for ABFM Diplomates. The new website, available at http://www.theabfm.org , is designed ... a responsive design, providing functional access from a desktop, a tablet, or smartphone, ...
(Date:3/20/2019)... ... March 20, 2019 , ... Natreon has been ... of trivalent chromium chloride combined with extracts of amla and shilajit, that has ... patent, along with 7 clinical studies on Crominex®3+, establish this ingredient as the ...
Breaking Medicine News(10 mins):
(Date:3/20/2019)... ... March 20, 2019 , ... ... services and products, announced today that it has partnered with ZRx Outcomes ... company offers RWE research, systematic literature review, comparative effectiveness research (CER), decision ...
(Date:3/20/2019)... ... March 20, 2019 , ... NDA Partners Chairman ... with extensive experience in the development of generic drugs and drug/device combination products at ... as an Expert Consultant. , During his career with FDA, Mr. Gonitzke served as ...
(Date:3/19/2019)... ... 2019 , ... TreTap Launches First-Ever CBD Infused Organic Tree Water Beverage , ... winner will receive TreTap beverages for a year , One of Vermont’s fastest ... Tretap, which was acquired by Vermont’s original CBD store - Ceres Natural Remedies - ...
Breaking Medicine Technology:
Cached News: